Reference : Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination w...

	Document type :	Scientific congresses and symposiums : Poster
	Discipline(s) :	Human health sciences : Oncology Human health sciences : Cardiovascular & respiratory systems
	To cite this reference:	http://hdl.handle.net/2268/83004

Title :	Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination with cisplatin versus etoposide-cisplatin as first-line treatment in patients (pts) with extensive disease small cell lung cancer (ED SCLC).
Language :	English
Author, co-author :	Bosquee, Léon [Université de Liège - ULg > > Pneumologie-Allergologie >]
Publication date :	2010
Audience :	International
Event name :	2010 ASCO - Annual Meeting
Event date :	du02 juin 2010 au 10 juin 2010
Event place (city) :	Chicago
Event country :	Etats-Unis
Permalink :	http://hdl.handle.net/2268/83004

	File(s) associated to this reference
	Fulltext file(s): File Commentary Version Size Access Open access Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination with cisplatin versus etoposide-cisplatin as first-line treatment in patients (.pdf Publisher postprint 1.13 MB View/Open

All documents in ORBi are protected by a user license.

 

© ULg Library Network |  Feedback |  ORBi legal notices

Dspace v1.5